2016_SUNY_Optometry_PRR

 Move topics of oncology, dermatology and laboratory testing from ocular disease II into human bioscience sequence III to maintain logical flow of information with appropriate sections of the course. Equivalent lecture hours could be transferred from Ocular disease II to Human bioscience III.  Elaborate further on the etiology, signs and symptoms of infectious disease in the microbiology and immunology course without any increase in the lecture hours.  Revisit selected systemic disorders that more commonly impact the health of the visual system in a newly created instructional unit that would support the integration of the knowledge gained from previous courses (human bioscience sequence, microbiology and immunology, general and ocular pharmacology) and discuss the systemic conditions in the context of the visual system. This unit will focus more on the clinical management of the different systemic conditions with additional emphasis on the impact of the disease on the visual system and its management vis a vis the management of the systemic condition. This instructional unit can be organized in the form of short lectures and grand rounds format case discussions with the involvement of guest faculty from other medical professions e.g., cardiology, endocrinology, rheumatology and infectious disease. Suggestions for specific topics include  Retain the topics of stroke, headache, neurological and psychological disorders in ocular disease III.

Lectures (18 hrs) Dermatology (2 hrs) Oncology (2 hrs) Hypertension and Atherosclerosis (2 hrs)

Cardiac disease (2 hrs) Diabetes Mellitus (2 hrs) Other endocrine diseases (2 hrs) Infectious disease (2 hrs)

Rheumatology (2 hrs) Pulmonology (2 hrs)

Small ‐ Group, Case ‐ Based Discussions (10 hrs) Cardiovascular Disease (2 hrs) Infectious diseases (2 hrs) Rheumatologic disease (2 hrs) Endocrine disease (2 hrs) Oncology (2 hrs) Neurological Disease (To be covered with Ocular Disease III)

Placement within the Curriculum Ideally the new course should be presented after the students have completed most of the prerequisite courses (Human bioscience, microbiology/immunology, general and ocular pharmacology, ocular disease I and II) and prior to Part I of the NBEO which covers topics related to clinical medicine. Placement in the fall or early part of spring semester of the third year would be ideal. Summer of 3 rd

2